Curcumin Protects against Ovariectomy-Induced Bone Changes in Rat Model

Area of Science:

• Biomedical Science
• Pharmacology
• Bone Biology

Background:

• Osteoporosis is a metabolic bone disease prevalent in postmenopausal women.
• Estrogen deficiency after ovariectomy leads to significant bone loss.
• Curcumin, a compound from turmeric, exhibits various medicinal properties.

Purpose of the Study:

• To investigate the potential of curcumin in preventing bone loss induced by ovariectomy in rats.
• To compare the efficacy of curcumin with Premarin (estrogen therapy) in a rat model of osteoporosis.

Main Methods:

• Thirty-two female Sprague-Dawley rats were divided into four groups: Sham, ovariectomized control, ovariectomized treated with curcumin (110 mg/kg), and ovariectomized treated with Premarin (100 μg/kg).
• Treatments were administered daily via oral gavage for 60 days.
• Bone structural parameters (bone volume, trabecular number, thickness, separation), osteoblast and osteoclast counts, and eroded surface were analyzed.

Main Results:

• Ovariectomy led to deteriorated bone structure, reduced osteoblast counts, increased osteoclast counts, and increased eroded surfaces compared to the Sham group.
• Curcumin treatment effectively reversed ovariectomy-induced bone loss and cellular changes.
• Curcumin demonstrated comparable efficacy to Premarin, showing superior results in bone volume and reduced eroded surface.

Conclusions:

• Curcumin shows significant potential in preventing bone loss associated with postmenopausal osteoporosis.
• Curcumin treatment can restore bone structural integrity and modulate bone cell activity (osteoblasts and osteoclasts).
• Curcumin may serve as a viable alternative to estrogen therapy for managing osteoporosis.